{
 "ok": true,
 "cik": "1468492",
 "ticker": "HSCS",
 "name": "HeartSciences Inc.",
 "filings": [
  {
   "form": "8-K",
   "filed": "2026-09-17",
   "items": [
    "7.01 Regulation FD Disclosure",
    "8.01 Other Events",
    "9.01 Financial Statements and Exhibits"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1468492/000121390026100752/0001213900-26-100752-index.htm"
  },
  {
   "form": "8-K",
   "filed": "2026-09-15",
   "items": [
    "2.02 Results of Operations and Financial Condition",
    "9.01 Financial Statements and Exhibits"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1468492/000121390026100185/0001213900-26-100185-index.htm"
  },
  {
   "form": "10-Q",
   "filed": "2026-09-14",
   "items": [],
   "url": "https://www.sec.gov/Archives/edgar/data/1468492/000143774926030319/0001437749-26-030319-index.htm"
  },
  {
   "form": "8-K",
   "filed": "2026-08-20",
   "items": [
    "7.01 Regulation FD Disclosure",
    "9.01 Financial Statements and Exhibits"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1468492/000121390026091893/0001213900-26-091893-index.htm"
  },
  {
   "form": "8-K",
   "filed": "2026-08-19",
   "items": [
    "7.01 Regulation FD Disclosure",
    "9.01 Financial Statements and Exhibits"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1468492/000121390026091720/0001213900-26-091720-index.htm"
  },
  {
   "form": "8-K",
   "filed": "2026-08-18",
   "items": [
    "1.01 Entry into a Material Definitive Agreement",
    "3.02 Unregistered Sales of Equity Securities",
    "9.01 Financial Statements and Exhibits"
   ],
   "url": "https://www.sec.gov/Archives/edgar/data/1468492/000121390026091301/0001213900-26-091301-index.htm"
  }
 ],
 "events12m": 21,
 "sources": {
  "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001468492.json",
  "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1468492"
 },
 "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.",
 "notAdvice": "Reporting, not investment advice. No price targets, no buy or sell views.",
 "edgar": "🫧 Edgar looked up HeartSciences Inc. ($HSCS). Last filing: 8-K (7.01 Regulation FD Disclosure), 2026-09-17. 21 event filings (8-K) in the past twelve months.",
 "auditor": {
  "changes": [],
  "nonReliance": [],
  "restatedSince": null
 },
 "metrics": {
  "fiscalYearEnd": "2026-04-30",
  "revenue": 4319,
  "revenueGrowth1y": -0.00712643678160918,
  "revenueGrowthPerYear": -0.25961272726653584,
  "yearsOfData": 5,
  "operatingMargin": -1947.8738133827276,
  "operatingMarginPrior": -1920.1312643678161,
  "netMargin": -2116.664737207687,
  "operatingCashFlow": -7426707,
  "capitalSpending": 3554,
  "freeCashFlow": -7430261,
  "researchAndDevelopment": 2839012,
  "researchShareOfRevenue": 657.3308636258394,
  "cash": 1700000,
  "longTermDebt": null,
  "longTermDebtChange": null,
  "revenueHistory": [
   {
    "fiscalYearEnd": "2022-04-30",
    "revenue": 14373
   },
   {
    "fiscalYearEnd": "2023-04-30",
    "revenue": 5150
   },
   {
    "fiscalYearEnd": "2024-04-30",
    "revenue": 18600
   },
   {
    "fiscalYearEnd": "2025-04-30",
    "revenue": 4350
   },
   {
    "fiscalYearEnd": "2026-04-30",
    "revenue": 4319
   }
  ],
  "totalEquity": 226060,
  "totalAssets": null,
  "equityRatio": null,
  "returnOnEquity": -40.440038042997436,
  "dividendsPaid": null,
  "payoutRatio": null,
  "dividendPerShare": 0,
  "dividendYearsRising": 0,
  "dividendCut": false,
  "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.",
  "range80": {
   "low": 3068.1297774780837,
   "high": 5509.1721225788515,
   "baseline": 4180.582882515443,
   "n": 749,
   "band": "b00"
  },
  "ifPaceHeld": {
   "low": 3068.1297774780837,
   "high": 5509.1721225788515
  }
 },
 "edgarette": "🔖 Exposure: revenue $4K (FY2026). Experience: revenue down 0.7% on the year, down 26.0% a year over 4 years; operating margin -194787.4%, down from -192013.1%. Soundness: return on equity -4044.0%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $3K and $6K next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A range, not a forecast. Against peers (36 filers, $50M+ revenue, finance services): operating margin -194787.4% against a -6.4% median; growth -0.7% against 16.8%.",
 "peers": {
  "sic": 6199,
  "sicDescription": "Finance Services",
  "calendarYear": 2025,
  "minRevenue": 50000000,
  "depth": 4,
  "group": "6199",
  "growth": [
   0.1678,
   51
  ],
  "opMargin": [
   -0.0639,
   36
  ],
  "equityRatio": [
   0.4195,
   46
  ],
  "returnOnEquity": [
   -0.0512,
   41
  ]
 },
 "summary": "HeartSciences (HSCS) saw revenue fall 0.7% in FY2026 to $0 million, operating margin -194787% against a -6.4% median for finance services. Every figure is from the company’s own annual report filed with the SEC.",
 "chart": "<figure class=\"cmp\"><figcaption>HeartSciences Inc. against its own record and its peers</figcaption><svg viewBox=\"0 0 560 112\" width=\"100%\" role=\"img\" aria-label=\"Comparison chart\"><rect x=\"0\" y=\"0\" width=\"560\" height=\"112\" fill=\"none\"/><text x=\"0\" y=\"34\" font-size=\"11\" fill=\"#6f6450\">Operating margin</text><rect x=\"148\" y=\"25\" width=\"338\" height=\"10\" rx=\"5\" fill=\"#efe7d6\"/><line x1=\"260.66666666666663\" y1=\"21\" x2=\"260.66666666666663\" y2=\"39\" stroke=\"#cfc5ae\" stroke-width=\"1\"/><line x1=\"224.66966666666667\" y1=\"20\" x2=\"224.66966666666667\" y2=\"40\" stroke=\"#c9a84c\" stroke-width=\"2.5\"/><title>Peer median -6.4%</title><circle cx=\"148\" cy=\"30\" r=\"6\" fill=\"#0a2240\" stroke=\"#fff\" stroke-width=\"1.5\"/><text x=\"494\" y=\"34\" font-size=\"11\" font-weight=\"700\" fill=\"#0a2240\">-194787.4%</text><text x=\"0\" y=\"60\" font-size=\"11\" fill=\"#6f6450\">Revenue, on the year</text><rect x=\"148\" y=\"51\" width=\"338\" height=\"10\" rx=\"5\" fill=\"#efe7d6\"/><line x1=\"292.8571428571429\" y1=\"47\" x2=\"292.8571428571429\" y2=\"65\" stroke=\"#cfc5ae\" stroke-width=\"1\"/><line x1=\"373.88057142857144\" y1=\"46\" x2=\"373.88057142857144\" y2=\"66\" stroke=\"#c9a84c\" stroke-width=\"2.5\"/><title>Peer median 16.8%</title><circle cx=\"289.416091954023\" cy=\"56\" r=\"6\" fill=\"#0a2240\" stroke=\"#fff\" stroke-width=\"1.5\"/><text x=\"494\" y=\"60\" font-size=\"11\" font-weight=\"700\" fill=\"#0a2240\">-0.7%</text><text x=\"0\" y=\"86\" font-size=\"11\" fill=\"#6f6450\">Return on equity</text><rect x=\"148\" y=\"77\" width=\"338\" height=\"10\" rx=\"5\" fill=\"#efe7d6\"/><line x1=\"232.5\" y1=\"73\" x2=\"232.5\" y2=\"91\" stroke=\"#cfc5ae\" stroke-width=\"1\"/><line x1=\"210.868\" y1=\"72\" x2=\"210.868\" y2=\"92\" stroke=\"#c9a84c\" stroke-width=\"2.5\"/><title>Peer median -5.1%</title><circle cx=\"148\" cy=\"82\" r=\"6\" fill=\"#0a2240\" stroke=\"#fff\" stroke-width=\"1.5\"/><text x=\"494\" y=\"86\" font-size=\"11\" font-weight=\"700\" fill=\"#0a2240\">-4044.0%</text><text x=\"0\" y=\"110\" font-size=\"10\" fill=\"#8b8375\">Gold tick: the median of 41–41 peers with $50M+ revenue in finance services</text></svg></figure>",
 "chartHorizon": "<figure class=\"cmp horizon\"><figcaption>Handed back now, or kept to compound</figcaption><svg viewBox=\"0 0 560 128\" width=\"100%\" role=\"img\" aria-label=\"Where the profit goes\"><text x=\"0\" y=\"14\" font-size=\"11\" fill=\"#6f6450\">Of each dollar of profit</text><text x=\"0\" y=\"76\" font-size=\"11\" fill=\"#6f6450\">Handed back per share</text><text x=\"250\" y=\"76\" font-size=\"11\" font-weight=\"700\" fill=\"#0a2240\">$0</text><text x=\"0\" y=\"94\" font-size=\"11\" fill=\"#6f6450\">Revenue growth it managed</text><text x=\"250\" y=\"94\" font-size=\"11\" font-weight=\"700\" fill=\"#0a2240\">-0.7%</text><text x=\"320\" y=\"94\" font-size=\"10.5\" fill=\"#8b8375\">last year, for comparison</text></svg><p class=\"cmpnote\">Gold is paid out to shareholders; navy is kept in the business. Retained profit times return on equity is the pace a company can fund from itself. Facts from the filings, not a recommendation.</p></figure>",
 "backtest": {
  "tests": 1,
  "hits": 0,
  "rate": 0,
  "method": "v3",
  "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample."
 },
 "registry": {
  "logged": "2026-09-20T15:23:44.786Z",
  "hash": "105fd55da787651b",
  "status": "open"
 },
 "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.",
 "schema": "pops4.edgarette.card/1",
 "card": {
  "summary": "HeartSciences (HSCS) saw revenue fall 0.7% in FY2026 to $0 million, operating margin -194787% against a -6.4% median for finance services. Every figure is from the company’s own annual report filed with the SEC.",
  "exposure": {
   "fiscalYearEnd": "2026-04-30",
   "revenue": 4319,
   "totalDebt": null,
   "cash": 1700000
  },
  "experience": {
   "revenueGrowth1y": -0.00712643678160918,
   "revenueGrowthPerYear": -0.25961272726653584,
   "operatingMargin": -1947.8738133827276,
   "operatingMarginPrior": -1920.1312643678161,
   "netMargin": -2116.664737207687,
   "freeCashFlow": -7430261
  },
  "soundness": {
   "equityRatio": null,
   "returnOnEquity": -40.440038042997436,
   "payoutRatio": null,
   "dividendPerShare": 0,
   "dividendYearsRising": 0,
   "dividendCut": false,
   "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown."
  },
  "peers": {
   "sic": 6199,
   "sicDescription": "Finance Services",
   "calendarYear": 2025,
   "minRevenue": 50000000,
   "depth": 4,
   "group": "6199",
   "growth": [
    0.1678,
    51
   ],
   "opMargin": [
    -0.0639,
    36
   ],
   "equityRatio": [
    0.4195,
    46
   ],
   "returnOnEquity": [
    -0.0512,
    41
   ]
  },
  "credibility": {
   "auditedYears": 5,
   "weight": "reasonable",
   "standard": "ASOP No. 25",
   "nonReliance": null,
   "auditorChange": null
  },
  "range": {
   "low": 3068.1297774780837,
   "high": 5509.1721225788515,
   "baseline": 4180.582882515443,
   "coverage": 0.8,
   "method": "v3",
   "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); range = 10th to 90th percentile of how SEC company-years of the same size band actually turned out",
   "calibratedOn": {
    "companyYears": 749,
    "sizeBand": "b00"
   },
   "kind": "a calibrated range, not a forecast; no view on the share price",
   "track": {
    "backtest": {
     "tests": 1,
     "hits": 0,
     "rate": 0,
     "method": "v3",
     "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample."
    },
    "registry": {
     "logged": "2026-09-20T15:23:44.786Z",
     "hash": "105fd55da787651b",
     "status": "open"
    },
    "scorecard": "https://www.pops4.com/boards/scorecard"
   }
  },
  "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.",
  "sources": {
   "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001468492.json",
   "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1468492"
  }
 },
 "definitions": {
  "operatingMargin": "Operating income divided by revenue.",
  "netMargin": "Net income divided by revenue.",
  "freeCashFlow": "Cash from operations minus spending on property and equipment.",
  "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.",
  "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.",
  "returnOnEquity": "Net income for the year against shareholders equity at year end.",
  "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.",
  "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.",
  "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.",
  "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.",
  "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.",
  "backtest": "The same if-the-pace-held arithmetic applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so."
 }
}